Optiver Holding
APGE

Optiver Holding’s Apogee Therapeutics APGE Stock Holding History

Optiver Holding’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.1K Buy
242
+94
+64% +$8.47K ﹤0.01% 1321
2026
Q1 		$12.5K Sell
148
-8
-5% -$581 ﹤0.01% 1180
2025
Q4 		$11.8K Sell
156
-114
-42% -$7.18K ﹤0.01% 1112
2025
Q3 		$10.7K Buy
+270
New +$10.3K ﹤0.01% 1255

Other funds holding APGE

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Optiver Holding's APGE Position: Q2 2026 in Review

Optiver Holding increased its Apogee Therapeutics (APGE) stake by 64% in Q2 2026, buying an estimated $8.47K and bringing the position to 242 shares worth $32.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1321.

Optiver Holding first reported a position in APGE in Q3 2025 and has held it in 4 quarters since. 289 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • Optiver Holding held 242 shares of Apogee Therapeutics worth $32.1K as of Q2 2026.
  • Optiver Holding bought 94 Apogee Therapeutics shares in Q2 2026, an estimated $8.47K.
  • Apogee Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1321 holding.
  • Optiver Holding first reported a position in Apogee Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 289 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.